Past Gallery
1-408-352-1010

WHAT ABOUT EVENT

On Tremendous success of our previous Breast Cancer Conferences, The 4th Global Insight Conference on Breast Cancer will take place in the splendid city of London, UK in July 18-20, 2019

A special invitation is extended to international colleagues to attend and contribute to the conference. Mark your calendars now and for more details please contact us at breastcancer@innovinc.org

about

WHO WE ARE?

To Meet renowned speakers, world's leading CEO's, Directors, decision and policy makers. To know about the ongoing research projects for Breast Cancer Research. To keep abreast of all advances in Breast Cancer. Chance to collaborate research organizations with industries.To share the research ideas and implement them in Breast Cancer diagnosis & Treatment. Best opportunity to reach the largest assemblage of participants from Breast Cancer Socities.

about

WHAT WE DO?

Our conferences are about you, our clients, so we work for unqualified success and we do that quietly, professionally and impeccably. We've built a reputation for creating and delivering inspirational conferences and executing them flawlessly first time round. We work really hard to achieve this and our success is down to the dynamics of a team who are down-to-earth.

about

WHY US?

INNOVINC conferences cover a broad range of research in the area of life science and technology. Attending a Innovinc Conference will provide immense access to ground-breaking research presentations and discussions which provides the best break to develop collaborations, get innovative ideas and opportunity for your own work.

About Conference

On Tremendous success of our previous Breast Cancer Conferences, The 4th Global Insight Conference on Breast Cancer will take place in the gorgeous city of London, UK in July 18- 20, 2019. Breast Cancer-2019 is designed to be a relaxed and friendly meeting where delegates and invited speakers have a chance to interact on both a scientific and social basis. Breast cancer represents the front runner in cancer research in many aspects. The Programme of this Conference includes lectures on molecular characterization, epidemiology, detection and diagnosis, metastatic breast cancer, updated treatments of early and advanced disease, surgery & radiotherapy, management of difficult cases and herary syndromes.

We welcome medical oncologists, pathologists, breast surgeons, radiation oncologists and basic scientists to listen to breast cancer leaders and to exchange experiences in a friendly atmosphere. Taking advantage of the unique offerings of London, there will be a huge number of attractive options for those wishing to extend their stay and bring their families with pre and post tours of London. Leisure time activities for delegates and guests will be offered to take full advantage of London.

DOWNLOAD BROCHURE
  • slider-home
  • slider-home
  • slider-home
  • slider-home
  • slider-home
  • slider-home
  • slider-home
  • slider-home

Scientific Sessions

Conference sessions may be geared toward participants with different levels of experience or different positions. Main conference sessions include the following 18 tracks. Choose to follow one track or move between tracks to create your own personalized conference experience.

Organizing Committee

Keynote Talks/Plenary Talks

Why to Attend

Innovinc International welcomes you to attend the 4th Global Insight Conference On Breast Cancer during July 18-20, 2019 at London, UK. To meet renowned speakers, world's leading CEO's, Directors, decision and policymakers.

To know about the ongoing research projects for breast cancer diagnosis and treatment. New contacts to enhance the business opportunities. Engage with high profile international and national speakers. Best opportunity to reach the largest assemblage of participants from cancer and oncology communities

VIEW ALL SPEAKERS

CONFERENCE AGENDA

day 1 agenda

Thu , Jul 18, 2019

  • 8:15
  • Registrations

  • 08:45
  • Introduction & Inauguration

  • 09:00
  • Keynote Talk 1:

    Title: Comprehensive proteomics analysis of breast cancer cell lines as it relates to targeted osmotic lysis
    Harry J Gould, LSU Health Sciences Center, USA

     

     

  • 09:30
  • Keynote Talk-2:

    Title: Application of ASTRO suitability criteria and 21-gene recurrence score results in breast cancer patients treated with intraoperative radiation therapy
    Barb schwartzberg, Sarah Cannon Research Institute, USA

  • 10:00
  • Keynote Talk-3:

    Title: Isolated thoracic perfusion in lung metastases from breast cancer
    Stefano GuadagniUniversity of Aquila, Italy

     

  • 10:30
  • Keynote Talk-4:

    Title: Isolated thoracic perfusion in lung metastases from breast cancer
    Acevedo Duncan Mildred, University of South Florida, USA

  • 11:00
  • Coffee Break

  • 11:20-13:10
  • Scientific Session-1

    Title: The impact of chemotherapy  modification  on the outcomes of breast and ovarian cancer patients
    Sigita Liutkauskienė, Lithuanian University of Health Sciences, Lithuania

  • Title: Intraductal Papilloma
    Gabriela Boufelli, ICESP/ HC/ FMUSP, Brazil

  • Title: Breaking breast cancer news” with ethnic minority: a UK experience
    Salma Naseem, UK

  • Title: Current Status of Korean Breast Cancer and New Technic Oncoplastic Surgery for Breast Cancer
    Nam-Sun Paik, Ewha Womans University Cancer Center Hospital for Women, South Korea

  • Title: Dual Action Catch and Release Photosensitizers for Targeting Triple Negative Breast Cancer
    Jeremy Kodanko, Wayne State University, USA

  • Title: A biology-driven technology for testing cancer drug efficacy and immunotherapies in vitro
    Silvia Scaglione, IEIIT , Italy

  • Title: A novel non-apoptotic approach to target TNBC
    Tiwari Amit K, University of Toledo, USA

  • 13:10 to 14:00
  • Lunch Break

  • 14:00 to 16:00
  • Scientific Session-2

    Title: Breast Cancer Genetics in Latin America
    Pablo Ruiz-Flores, Autonomous University of Coahuila, Mexico

  • Title: Antitumor Action of Amygdalin on Human Breast Cancer Cells by Selective Sensitization to Oxidative Stress
    Muayad Abboud, Hashemite University, Jordan

  • Title: A dual action glycotherapy for treating breast cancer
    Dipak K. Banerjee, University of Puerto Rico, USA

  • Title: Is it time to establish breast cancer as a smoking related cancer?
    Inger Torhild Gram, UiT The Arctic University of Norway, Norway

  • Title: Surgery of the Axilla ; Less is More
    Osama. Almalik, King Faisal Specialist Hospital and Research Center, Saudi Arabia

  • Title: Inhibition of Na+/K+ ATPase activity inhibits the proliferation, motility, and invasion of endocrine resistant breast cancer cells
    Maitham Khajah, Kuwait University, Kuwait

  • 16:00 to 16:15
  • Coffee Break

  • 16:15 to 16:35
  • Scientific Session-3

    Title: Interactions between cancer associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor positive breast cancers
    Philippe P. Juin, Université de Nantes, France

  • Title: Neoadjuvant therapy for breast cancer treatment: an expert panel recommendation from the Brazilian Society of Breast Surgeons 2018
    Fernanda Barbosa, Icesp / FMUSP / HIAE, Brazil

  • (16:55-17:15)SLOT AVAILABLE

  • Title: Thoracic manifestations of breast cancer 
    Ayda Hussein , Alneelain  university, Sudan

  • 17:35
  • Panel Discussions

    This is a tentative Scientific Program and subjected to change

day 2 agenda

Fri , Jul 19, 2019

  • 9:00
  • Keynote Talk-1

    Title: ELECTRON MICROSCOPY of tumorous mitochondria in 8 cases of different biologic types of invasive mammary carcinoma
    Sveta Silverman, University of Alberta, Canada

  • 09:30
  • Title: Real time fusion of breast MRI and breast ultrasound: new aspects in breast cancer assessment
    AMORT Birgit, University Hospital Innsbruck, Austria

  • 10:00
  • Keynote Talk-3

    Title: Update on Potential Biomarkers in Triple-Negative Breast Cancer 
    Yan Peng, University of Texas Southwestern Medical Center at Dallas, USA

  • 10:30
  • Keynote Talk-4

    Title:  A sneak peek through the AR lens: Our multi-institutional experience of TNBC landscape
    Ritu Aneja, Georgia State University, USA

  • 11:00
  • Coffee Break

  • 11:20-13:10
  • Scientific Session-1

    Title: Unique Signaling Pathways in Inflammatory Breast Cancer (IBC)
    Kenneth Louis van Golen, University of Delaware, USA

  • Title: Recommendations to reduce the risk of side effects after breast cancer surgery and treatments
    Tamar Jacob, Ariel University, Israel

  • Title: Potential value of PHLDA gene family members as a prognostic and predictive biomarker in breast cancer
    Nagai Maria Aparecida, Universidade de São Paulo, Brazil

  • Title: Is Axillary Web Syndrome a Risk Factor for Lymphedema?
    Pedro Ferreira, Centro Hospitalar Universitário Lisboa Norte - Hospital de Santa Maria, Portugal

  • Title: Immunotherapy in breast cancer: A new field in the therapeutic landscape of breast cancer with many perspectives.
    Nikos Mitsimponas, HYGEIA HOSPITAL, Greece

  • Title: Autologous Breast Reconstruction With the Latissimus Dorsi Muscle With Immediate Fat Grafting
    Renata Brondi, Faculdade de Ciências Médicas Santa Casa de São Paulo, Brazil

  • Title: Recent advances in peptidomimetics antagonists targeting estrogen receptor α-coactivator interaction in cancer therapy
    Zigang li, Peking University Shenzhen Graduate School, China

  • 13:10 to 14:00
  • Lunch Break

  • 16:20 to 17:40
  • Scientific Session-2

    Title: Clinical evolution and findings in bi-rads 3 lesions at the Hospital Alta Resolución
    Jack Antonio Diaz Brito, HOPITAL ALTA RESOLUCION ECIJA, Spain

  • Title: Abscopal Effect of Breast Cancer
    Azami Ayaka, Southern TOHOKU General Hospital, Japan

  • Title: BRCA Mutations: Cancer Risk and Genetic Testing
    TMU, sc.chang, Taipei Medical University, Taiwan

  • Title: A Novel Fzd7 Antibody XW-19O1 Shows Promising Activity against Triple Negative Breast Cancer
    Zhaoli Zhou, SUMHS, China

  • Title: Bevacizumab Addition in Neoadjuvant Treatment Increases the Pathological Complete Response Rates in Patients with HER-2 Negative Breast Cancer Especially Triple Negative Breast Cancer: A Meta-Analysis
    Jing ZhangSichuan University, China

  • Title: Bevacizumab Addition in Neoadjuvant Treatment Increases the Pathological Complete Response Rates in Patients with HER-2 Negative Breast Cancer Especially Triple Negative Breast Cancer: A Meta-Analysis
    Jing ZhangSichuan University, China

  • 16:00 to 16:20
  • Coffee Break

  • 16:20 to 17:40
  • Scientific Session-3

    Title: Association of miR‐1247‐5p expression with clinicopathological parameters and prognosis in breast cancer
    Peng Zhang, Peking University Shougang Hospital, China

  • Title: Periclitoral accessory breast tissue in a lactating woman: a case report
    Yanlin Song, Sihcuan university, China

  • Title: Introducing novel and comprehensive models for the prediction of recurrence in breast cancer using group LASSO approach: are estimates of early and late recurrence different?
    Tannaz Eghbali, Shiraz University of Medical sciences, Iran

  • Title: A Randomized Controlled Study of Breast Cancer Screening among Women from Faith-Based Communities in Israel: A Culturally-Tailored Intervention
    Anat Freund, University of Haifa, Israel

  • 17:40
  • Panel Discussions

    This is a tentative Scientific Program and subject to change..

day 3 agenda

Sat , Jul 20, 2019

  • 09:00 to 11:00
  • Scientific Session-1

    Title: The Use of a Microscope  with Near Infrared Imaging Function in Indocyanine Green Lymphography and lymphaticovenous Anastomosis for LYPMHA Immediately post  Mastectomy and Axillary Dissection and 3 years follow-up---3 Cases Report 
    LAN MU, Peking University People's Hospital, China

     

  • Title: Prevalence of BRCA1 and BRCA2 mutations among high risk Saudi breast cancer patients
    Omalkhair Abulkhair, Al Faisal University, Saudi Arabia

  • Title: Potential therapeutic strategies in Cancer
    Li-Pin Kao, East Carolina University, USA

  • Title: Primary Care Coordination with the Breast Unit of Hospital Alta Resolución Ecija
    Jack Antonio Diaz Brito, HOPITAL ALTA RESOLUCION ECIJA, Spain

  • Title: Caregiver burden among Nigerian Informal caregivers of Women with Breast Cancer
    Israel O. Gabriel, Ahmadu Bello University Teaching Hospital, Nigeria

     

  • (10:20-10:40SLOTS AVAILABLE

  • 11:00 to 11:15
  • Coffee Break

  • 11:15 to 13:15
  • Scientific Session-2

    Title: Changes from head to vagina after treatment affect the intimate relationship between partners?
    Yun-Chen ChangNational Taiwan University, Taiwan

  • Title: Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer
    Thuluz Meza-Menchaca, Universidad Veracruzana, Mexico

     

  • SPEAKER SLOT AVAILABLE

  • SPEAKER SLOT AVAILABLE

  • SPEAKER SLOT AVAILABLE

  • SPEAKER SLOT AVAILABLE

  • 13:15 to 14:00
  • Lunch Break

    This is a tentative Scientific Program and subject to change...

Conference Agenda Download

HURRY UP! ONLY 150 SEATS REMAINING CURRENTLY…

Don t Miss This Amazing Conference And Opportunities

Past Conference Gallery

Promote Partners